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Abstract
A challenge of systems biology is to integrate incomplete knowledge on pathways with existing experimental data sets and
relate these to measured phenotypes. Research on ageing often generates such incomplete data, creating difficulties in
integrating RNA expression with information about biological processes and the phenotypes of ageing, including longevity.
Here, we develop a logic-based method that employs Answer Set Programming, and use it to infer signalling effects of
genetic perturbations, based on a model of the insulin signalling pathway. We apply our method to RNA expression data
from Drosophila mutants in the insulin pathway that alter lifespan, in a foxo dependent fashion. We use this information to
deduce how the pathway influences lifespan in the mutant animals. We also develop a method for inferring the largest
common sub-paths within each of our signalling predictions. Our comparisons reveal consistent homeostatic mechanisms
across both long- and short-lived mutants. The transcriptional changes observed in each mutation usually provide negative
feedback to signalling predicted for that mutation. We also identify an S6K-mediated feedback in two long-lived mutants
that suggests a crosstalk between these pathways in mutants of the insulin pathway, in vivo. By formulating the problem as
a logic-based theory in a qualitative fashion, we are able to use the efficient search facilities of Answer Set Programming,
allowing us to explore larger pathways, combine molecular changes with pathways and phenotype and infer effects on
signalling in in vivo, whole-organism, mutants, where direct signalling stimulation assays are difficult to perform. Our
methods are available in the web-service NetEffects: http://www.ebi.ac.uk/thornton-srv/software/NetEffects.
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Introduction
A major challenge in systems biology is the integration of
different types of knowledge about biological processes in order to
gain insight into the functioning of the organism as a whole system.
Experimental data can include detailed molecular quantification
experiments and records of phenotypic traits. Much of the time,
knowledge such as pathway information is incomplete and is
described at varying levels of detail in published records.
Experimental data are usually specific to the question they were
designed to address, limiting their power to shed light on more
general properties of the system or to address different questions.
In many cases the choice of the biological system, limits the type of
experiments that can be performed, therefore relying on
computational methods to make additional inferences. As we
accumulate more knowledge about biological processes, it is
important to review past experiments in the light of new
knowledge, in order to extract further understanding of the
system. An additional challenge is to bridge the gap between
knowledge of biological pathways, genetic perturbations with their
effects on gene expression and the resulting phenotypes, in order
to gain a more thorough understanding of biological mechanisms.
In this study, we developed a method for integrating pathway with
gene expression and phenotypic data sets, making inferences from
them and checking their consistency. These include information
on changes in gene expression resulting from different gene
mutants, biological signalling pathway information at the protein
level in the form of activation and inhibition between proteins, and
results of phenotypic analyses of the mutant animals.
Ageing is the process of decline in organismal fitness over time.
This process differs significantly across species, as well as between
individuals of the same species, leading to a variety of different
age-related phenotypes and lifespans. The molecular basis of
lifespan has been under intense investigation in recent years, using
laboratory model organisms such as yeast, the nematode worm
Caenorhabditis elegans, the fruit fly Drosophila melanogaster and the
mouse Mus musculus. The insulin/insulin-like growth factor
signalling (IIS) pathway and the target of rapamycin (TOR)
pathway have been found to be major determinants of lifespan in
these organisms. Importantly, as well as extending lifespan
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through the forkhead transcription factor foxo, reduction of IIS
activity increases health during ageing. Initial experimental work
showed that worm mutants for daf-2, the single worm IIS receptor,
live twice as long as controls [1,2]. Similar results from various
components of the IIS pathway have been observed in flies [3,4]
and mice [5–8]. These findings have emerged from genetic
manipulations of the ageing process, by targeting specific
components of the IIS signalling network and measuring the
responses of lifespan and, in some cases, genome wide patterns of
gene expression. For a review of experiment types in ageing and
computational methods available for their analysis, see [9]. Given
the complexity and incomplete knowledge of the signalling
pathways involved, it is often difficult to examine the transcrip-
tional changes in the context of the signalling pathway architec-
ture.
Protein abundance is predominantly controlled at the level of
translation [10]. A recent study by Schwanha¨usser et al [11] found
that about 40% of variance in protein abundance is explained by
mRNA levels in mammalian cells. This study showed that
transcription factors and signalling molecules, in particular, have
short mRNA and protein half-lives possibly because these are
information carrying molecules, whose levels must be rapidly
adjusted in response to environmental changes. Moreover,
Nagaraj et al [12] report a good correlation of protein abundance
with transcript abundance in cancer cell lines. It is therefore
possible to make some, qualitative inferences about signalling
pathways from mRNA levels in gene expression studies. In
addition, genetic manipulations of the IIS pathway cause FOXO-
mediated transcriptional responses in downstream pathways, as
well as transcriptional feedback on upstream components of the
IIS pathway [13,14]. Previous studies (e.g. [15,16]) report
feedback at the transcriptional level, but this has not been
examined across different mutants, longevity phenotypes and
within the framework of the IIS and its neighbouring signalling
pathways.
Here we develop a qualitative method that enables us to infer
the impact of differential gene expression on signalling pathways
and attempts to distinguish the effects of the primary experimental
intervention from those caused by feedback. We achieve this by
developing a comprehensive model of the pathways involved and a
rule-based logical theory that integrates results from high-
throughput gene expression assays with previous knowledge of
the pathway. In this study we have used such data sets from in vivo
experiments on ageing of the fruit fly Drosophila melanogaster, where
direct experimental measurements of signal transduction by means
of ligand stimulations are difficult to perform. Previous work on
the inference of signalling pathway components from gene
expression data sets has focused on inferring modulators of
specific transcription factors by correlating mRNA expression
profiles across large sets of microarray experiments [17,18]. These
methods rely on the availability of large sets of expression data and
do not make use of any prior knowledge of the signalling pathway
that modulates the transcription factor. In contrast, our approach
combines previous knowledge of the pathway architecture and
limited data on gene expression with logic, to obtain additional
insights.
The modulation of small scale signalling pathways has
previously been modelled by Ordinary Differential Equations
(ODEs) that can represent chemical reactions. Networks of these
equations can model biochemical processes in detail, provided
there are appropriate experimental data sets to estimate the
parameters of the model. This approach requires proteomic and
phosphorylation experiments assessing the abundance of the
different forms of the molecules so that the reaction parameters
can be quantified. Although these models are very useful in
describing specific reactions and small pathways [19], it is not very
often that such experimental data sets are available for larger
pathways with many nodes. Such ODE modelling is computa-
tionally intensive, so that simulations using networks larger than a
few nodes are limited.
Methods using boolean logic and fuzzy logic have been
successfully applied to simulate signalling pathways and study
their activity under different conditions, such as targeted gene
mutations or ligand stimulations. Calzone et al [20] use the
software GinSim, [21], to model the regulation of cell-fate decision
and identify conditions under which a cell decides to proceed with
apoptosis, survival or non-apoptotic cell death using a network of
14 nodes, reduced from a literature-derived network of 28 nodes.
These methods are based on the development of transition graphs,
synchronous or asynchronous, although asynchronous transition
graphs resemble more closely the signalling pathway mode of
action. Although powerful for solving highly connected small
networks with loops, the time required for analysis of these graphs
is exponential, leading to computational difficulties when dealing
with pathways containing larger numbers of nodes. Saez-
Rodriguez et al [22] developed CellNetOpt to successfully optimise
pathway models against high-throughput biochemical measure-
ments of phosphorylation states. For a more comprehensive review
on logic-based models, see [23].
Our approach uses Answer Set Programming (ASP), a
methodology for declarative programming that supports logic-
based inference, [24]. ASP provides a flexible and expressive
framework for describing theories, and benefits from the
development of efficient solvers, such as the Potsdam answer set
solving collection [25]. ASP has been used to model the sulfur
starvation-response pathway of Arabidopsis thaliana using action
languages on ASP [26] and model cell cycle networks in yeast [27].
Later, Fayruzov et al, [28], adapted their ASP framework to
behave as a boolean network. They conclude that their approach
is more expressive than boolean networks, due to the flexibility of
representing implicit assumptions and background knowledge, as
well as the scalability for expressing special cases with the ASP
framework. Recently, it was applied to the development of BioASP
[29], a python library that provides tools for checking the
consistency between experimental data and pathways and suggest
new pathway links that could improve the fit between experiments
and pathways. BioASP expresses and extends, with use of ASP, the
Sign Consistency Model (SCM) that is employed by the cytoscape
plug-in BioQuali [30]. Finally, Videla et al, [31], have recently
compared the training of logic models of signalling networks using
optimisation heuristics with a new implementation based of
Answer Set Programming. Their assays showed significant
improvements on computation time by the use of ASP. In
addition, their ASP implementation was able to identify all
possible solutions as opposed to the stochastic optimisation
method.
In this study we constructed a model of the IIS signalling
pathway including its interactions with the TOR pathway and
developed a novel method for inferring the modulation of the
pathways from large-scale gene expression data sets using data
from different mutants affecting longevity. Our resulting rule-
based theory enables the inference of effects in a large and
complex pathway, implicitly checking experimental consistency,
by using a single expression data set at a time. It is also possible to
make a custom query of the pathway components the user wishes
to perturb and predict the effects on signalling and the phenotype.
By using qualitative data sets and an ASP solver, we avoid the
computational limitations faced by other methods, and we are
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hence able to work with larger complex pathways that include
feedback loops and make the methods available as a web-service.
By using prior knowledge of the pathway connections, we
overcome the requirement for a large number of experimental
data sets for our inferences. Our analyses focus on experimental
data sets from Drosophila melanogaster that manipulated the genes
chico, Lnk, foxo and InR to produce a significant difference in
lifespan between mutant and wild type strains. We analyse one
experiment at a time and we also provide new methods for the
comparisons of our inferences across experiments. The methods
are implemented in a web-service, NetEffects, http://www.ebi.ac.
uk/thornton-srv/software/NetEffects, allowing users to analyse their
expression and longevity data using this approach, or to predict
probable effects on longevity for mutations to any components of
the pathway.
Methods
A model of the Drosophila insulin pathway and its
interaction with the TOR pathway
The IIS signalling pathway and its interactions with the TOR
pathway are shown in Figure 1. The IIS pathway is a
neuroendocrine pathway, whose single receptor, INR, can be
activated by seven different insulin-like peptides (ILPs) present in
Drosophila. INR activation leads to the recruitment of the single
Drosophila insulin receptor substrate CHICO and of the Drosophila
homologue of human SH2B, called LNK. These proteins act in
parallel and activate the phosphotidylinositol-3-kinase (PI3K)
complex formed by proteins P60 and P110 [32]. The PI3K
activates the phosphoinositide-dependent kinase-1 PDK1, leading
to the activation of the protein kinase B, AKT1, which inhibits the
activity of the forkhead transcription factor FOXO. This core
signal transduction pathway is modulated by numerous other
proteins, such as the cytohesin, STEP, [33], B4/SUSI [34],
PHLPP [35], or the IGFBP7 homologue imaginal morphogenesis
protein-late-2 (IMP-L2) [36].
The insulin pathway interacts with other signalling pathways,
such as the JNK kinase, SOS signalling and Wnt pathways. It is
also highly interconnected with the target-of-rapamycin (TOR)
pathway, mainly mediated through CHICO, PI3K and AKT1 in
the IIS and the TSC-complex, L (LOBE), TOR-C2 and S6K in
the TOR pathway. The core TOR pathway is triggered by low
intracellular AMP levels, which activate the AMP kinase SNF1A,
which in turn activates the TSC-complex. The complex inhibits
RHEB, which then no longer activates the TOR-C1 complex.
The TOR-C1 complex is a major signalling complex integrating
various signals and activating and inactivating numerous proteins
amongst which are transcription factors such as the Drosophila
MYC/DM, as well as signalling proteins, such as S6K.
The complex network of these interactions has been manually
compiled from pathway diagrams of the KEGG database [37,38]
and an extensive literature review based on review articles [39,40],
as well as the primary literature, e.g. [41,42]. In cases of doubt or
incomplete information, interactions and the logical connections
have been cross checked for experimental evidence in Drosophila
melanogaster. While we have tried to cover the two pathways and
their interactions as completely as possible, the diagram is
undoubtedly incomplete because of the limits of biological
knowledge.
The diagram has been created in GraphML using the program
yEd (http://www.yworks.com). This is an XML based format,
which allows a formal interpretation, while at the same time
defining a graphical layout. It thus enables a graphical
representation, which is immediately understandable to biological
readers and at the same time allows computational use of the same
file. The diagram shows activation and inhibition relationships of
the protein components of the signalling network, thus represent-
ing the activity wiring. Metabolic, transcriptional or translational
influences are not considered. For tractability, we do not include
any kinetic data or location-specific information in the pathway.
These compromises in complexity are essential to allow the
examination of such a large and complex signalling network.
However, our approach is far more detailed than pure protein-
protein-interaction studies, which lack directionality and connec-
tion types (i.e. induces/inhibits).
Finding signals from expression data sets
We applied our methods to microarray gene expression studies
of three different genetic null mutants (chico1/+, LnkDel29=Del29,
dfoxoD=D) and one loss of protein function (daGAL4wUAS-dInRDN )
in components of the IIS pathway. Three of those conditions, chico
(chico1/+), Lnk (LnkDel29=Del29) and InR (daGAL4wUAS-dInRDN ),
result in lifespan-extension of Drosophila melanogaster. The fourth
condition, foxo, (dfoxoD=D) results in lifespan-reduction and is a
homozygous deletion of the forkhead box O transcription factor,
whose function is inhibited by the activation of insulin signalling.
The Lnk experiment generated homozygous mutants null for the
gene Lnk, whereas the chico experiment generated a heterozygous
mutant of the gene chico. The InR experiment involved an over-
expression of a dominant negative form of the gene InR. RNA
expression microarray assays were performed on whole flies for all
experiments, except for Lnk, where the assays where performed on
fly heads only. These studies are publicly available in [15,16,43].
Each microarray data set was analysed, to identify the set of
differentially expressed genes. Raw data sets were summarised and
normalised using RMA [44–46] and quantile normalisation as
implemented in the LIMMA package. Differential expression
between mutants and wild-type controls was assessed using linear
models and the empirical Bayes moderated t-statistic implemented
in LIMMA [47]. Highly differentially expressed genes were
selected by applying a 0.005 cutoff on the adjusted P-value for
each experiment. The analysed data sets are available in
supplementary file S4. In Figure 2 we show which genes, in the
IIS and TOR pathways, are differentially expressed in each
experiment.
Then we used the workflow summarised in Figure 3, in order to
infer possible signalling paths within each experiment. We used as
inputs the pathway and the microarray results, together with
information on the experimental perturbation to build a knowl-
edge base of facts for each experiment. Using the general logic
program that links those facts with potential outcomes for the
signalling of the proteins involved, we inferred how the
perturbation and subsequent differential expression could influ-
ence the activation of the different pathway components at the
signalling level. Figure 4 illustrates this process by use of a small
example. This step uses ASP and consists of the two steps of
‘grounding’, augmenting the facts by use of the logic program, as
described in Supplementary Files S2 and S5, that in essence
assigns values to the variables according to the facts and rules, and
‘solving’, filtering the ground sets using the rules and integrity
constraints to find consistent answer sets. We used the publicly
available grounder ‘gringo’ and solver ‘clasp’, as described in the
Supplementary File S5, to output sets of ‘activates’ and
‘inactivates’ relations. Each one of the experiments yielded one
answer set.
The final step involved the inference of paths using each
differentially expressed or perturbed pathway component as a
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starting point and longevity as an endpoint. For most differentially
expressed or perturbed components, there is a large number of
paths leading to the phenotype. This is due to the several
connections between the IIS and the TOR pathways that lead to
the generation of loops. We use the shortest paths in some of the
analyses to show the direct effects of the perturbation or
differential expression to the phenotype. We also use all the paths
generated in order to derive feedback routes that could play a role
in the signalling pathway modulation within each mutant (analyses
shown in later sections). All paths are available in Supplementary
File S1 and the shortest paths per experiment are shown in
Table 1.
At this stage we used the phenotype recorded by the survival
analyses that accompanied each experiment, in order to classify
the inferred paths into ‘primary’ or ‘secondary’ effects. We call
primary effects those paths that support the observed longevity
phenotype and involve the primary experimental mutation.
Secondary effects refer to paths that are triggered by differential
expression of genes, other than the primary mutant. These are
further classified into negative and positive feedback, where effects
of negative feedback contradict the observed longevity phenotype,
whereas positive feedback effects support the observed phenotype.
Searching for longest common sub-paths
By comparing the different paths produced within and across
the different experiments, we observed that many non-identical
signals contained similar ‘‘segments’’ of paths that could poten-
tially reveal important recurrent routes of activity in the signalling
pathway. For example, each one of the long-lived mutants up-
regulates different insulin-like peptides (ILPs) that in turn can lead
to changes in longevity as mediated by FOXO (Table 2). When
comparing whole paths between experiments, these similarities are
missed, since the starting point (the ILP molecule) differs between
paths, even though the rest of the path is the same. Moreover, by
looking only at the shortest paths in an experiment, the
information that can be derived from the rest of the paths is
missed. We therefore developed a method to extract common sub-
paths (routes) from all the paths per experiment and then compare
these across experiments. These sub-paths highlight the routes that
are accessible in a mutant, given the architecture of the pathway,
the mutations and differentially expressed components.
In order to be able to identify the most common sub-paths
within or across experiments, we developed a ‘‘longest common
sub-path finder’’. A sub-path is defined as a sequence of
‘activates’/‘inactivates’ relations that is part of a path that has a
differentially expressed or perturbed component as a starting point
and longevity as an end point. The longest common sub-path
Figure 1. The insulin pathway in Drosophila. Insulin signalling pathway and its interconnections with the TOR pathway. The insulin pathway
appears on the left-hand side towards the centre of the image, while the TOR pathway appears on the right-hand side. There are many connections
facilitating cross-talk between the two pathways. Black arrows represent activating connections, while red-T-lines represent inhibitions. Green
rectangular boxes represent proteins, while trapezoid boxes represent processes or pathways. We use the Flybase gene symbols as names but also
include other commonly used names, in cases where these are appear more frequently in the literature. Protein-complexes are represented by boxes
whose name always begins with ‘‘c_’’. Transcription factors are shown by octagons, but only some examples are shown. The FM-longevity (FOXO-
mediated longevity) phenotype is represented by a hexagon.
doi:10.1371/journal.pone.0050881.g001
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finder takes as input all the different paths produced by the
analysis of the results from ASP and outputs a list of common sub-
paths, together with their frequency in the data set. The algorithm
uses an existing solution of the ‘longest common string’ program,
implemented in the Perl package (String-LCSS-0.12, available
from the Comprehensive Pearl Archive Network, www.cpan.org).
Every path is compared to each other and the longest common
sub-string is found for each comparison. The occurrences of each
sub-string (sub-path) are counted and returned. The algorithm
takes into account the sequence of nodes (pathway components), as
well as their status (activated or inactivated). The longest common
sub-path finder program is available for download from http://code.
google.com/p/longest-common-sub-path.
Results
Identifying general trends between experiments
We observed that in all cases, the shortest paths starting from
the mutated component support the observed phenotype, as
expected, whilst most of the shortest paths starting from the
differentially expressed components predict the opposite pheno-
type, suggesting negative feedback responses to the genetic
perturbation, triggered at the transcriptional level.
We first compared the whole paths inferred by our methods
across experiments. Only the experiments that mutated the chico
and Lnk genes had some paths in common. This is not surprising,
since these experiments mutate genes whose products function in a
parallel fashion, by transmitting a signal from the receptor INR to
the PI3K complex.
Then, we produced the most common sub-paths for each
experiment (available in supplementary file S3). These reveal the
routes which most commonly occur in the response paths per
experiment. Then, we compared the sub-paths across experi-
ments, by asking three different questions. First, we looked for the
most common sub-path in all long-lived mutants, which was the
link from AKT1 to FOXO and longevity. The sub-paths of the
Lnk and InR experiments were generally more similar than those in
chico, although we did not observe any similarities between whole
paths of InR and Lnk. The sub-path that exists in Lnk and InR but
not in chico, corresponds to the secondary effect that reduces
longevity through FOXO inhibititon via inactivation of S6K and
subsequent activation of CHICO (Figure 5A). We looked into the
common links between other sub-paths that we could detect in
long-lived mutants, especially in Lnk and InR. These were various
links that could lead to secondary effects, involving AKT1
activation by the TOR-C2 complex (Figure 5B), in some cases
triggered by the inhibition of RHEB and subsequently TOR-C1
by the complex of TSC1 and TSC2 (Figure 5D), whereas in others
by the inhibition of L on TOR-C1 (Figure 5C). All these effects are
also detected within the paths inferred in chico, although they do
not appear as longest common sub-paths. Gene L appears to be
up-regulated in the InR mutant, where we infer a shortest path
Figure 2. Differentially expressed components of the insulin pathway for each experiment. Down-regulated genes appear in blue,
whereas up-regulated genes appear in red. Circled nodes represent the genetically manipulated components. Image (A) corresponds to the
experiment that mutated chico, (B) to Lnk, (C) to InR and (D) to foxo.
doi:10.1371/journal.pone.0050881.g002
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starting with L inhibition on TOR-C1, followed by TOR-C2 and
AKT1 activation, leading to lifespan reduction by FOXO
inactivation.
The current experiments and the connections on the pathway
map are too few to identify striking differences across experiments.
However, we do identify responses shared across all and one
response shared by two out of three long-lived experiments. These
routes could be of significance as they form part of the feedback
mechanism that might be similar across experiments but triggered
by different components. Specific examples are described in the
next sections.
Identification of opposite transcriptional feedback to
insulin signalling in short- and long-lived mutants
We initially looked at the shortest paths from each mutant or
differentially expressed component in the pathway to FOXO and
longevity. Looking at the shortest active paths only, as shown in
Table 1, we observe that primary effects in long-lived mutants
suppress insulin signalling whilst secondary effects tend to
stimulate the IIS pathway.
In contrast, in the foxo short-lived mutant we observe that the
primary effect is reduction of lifespan, as foxo has been directly
mutated. Therefore, no negative feedback can be inferred using
the default settings of our method, since it would require FOXO
being able to get activated. We do, however, observe differential
expression on other components of the signalling pathways that
would be consistent with suppressing insulin signalling by, for
example, down-regulating Ilp molecules. We call these ‘‘impaired
effects’’, since one or more components of the path are mutated or
differentially expressed in such a way that the signal is disrupted.
In the case of the down-regulation of the insulin-like peptides that
would normally suppress insulin signalling and activate FOXO,
the signal is disrupted by the experimental knocking out of foxo.
Moreover, in the foxo mutant we only infer positive feedback
secondary effects that suppress FOXO.
In all three long-lived mutants some of the Ilp molecules are up-
regulated, leading to FOXO inactivation, by retention in the
Figure 3. Flow chart of methods and data types. For the ‘grounding’ stage of ASP, with the tool ‘gringo’, we use our rule based representation
(logic program), the pathway relations and the appropriately encoded gene expression data sets (facts). Gringo, then produces all possible ground
facts, which are then handled by the solver, ‘clasp’, which uses the logic program with the integrity constraints to find consistent ‘answer sets’. Finally,
using our own custom made program for path searches, we process the answer sets to identify affected paths in the experiment using each
differentially expressed or mutant gene as a starting point and longevity as the end point. These paths are split into primary or secondary effects
using the information on the longevity phenotype, acquired by survival assays, complementary to each experiment.
doi:10.1371/journal.pone.0050881.g003
Figure 4. Example of applying the ASP methods on a short
pathway. This example pathway consists of three components which
are linked with two signalling interactions, where A induces B and B
inhibits C. If A is knocked out in an experiment, as shown by the symbol
‘X’, then the expression of the transcript of A will decrease (dark blue).
The effect of this decrease in expression, at the protein level of this
pathway, is that B (light blue) will remain inactivated by A and C (light
red) activated as a result of lack of inactivation by B.
doi:10.1371/journal.pone.0050881.g004
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cytoplasm and potentially a reverse effect to the observed lifespan-
extension. For instance, Ilp2, Ilp3 and Ilp5 are up-regulated in the
chico knock out, Ilp2, Ilp3, Ilp5 and Ilp6 appear up-regulated in the
Lnk mutant and Ilp6 is up in the InR mutant. In contrast, we
observed Ilp3 to be down-regulated in the short-lived foxo mutant,
leading to an ‘‘impaired’’ path that aims to activate FOXO by
suppressing insulin signalling.
Similarly, ImpL2, which inhibits ILP2 and ILP5 [36], appears to
be down-regulated in the long lived Lnk mutant, while it is up-
regulated in the short-lived foxo mutant. The aim, in this case too,
appears to be the reduction of the inhibition of insulin signalling in
the long-lived mutant, so that normal FOXO activity levels are
restored, while in the short-lived mutant, the insulin signalling is
reduced by inhibition of the ILPs. Hence, feedback in vivo involves
extracellular components, such as one or more of the ILPs or
IMPL2.
Looking at the signalling sub-paths we inferred for each
experiment, we also observed that the TOR-C2 inhibition by
the down-regulation of Tor and Sin1 in the foxo mutant could lead
to inactivation of AKT1 and consequent FOXO activation,
provided foxo was not knocked out, and lifespan extension. This
effect is not observed at all in the Lnk mutant, where we only
observe the opposite, TOR-C2 and AKT1 activation. In the chico
mutant we observe no sub-paths containing the link between
TOR-C2 and AKT1 and in the InR mutant we observe many
occurrences of activation of TOR-C2 and AKT1 and a few cases
of inactivation of TOR-C2 and AKT1, in long sub-paths that
contain loops through the IIS pathway (AKT1) and various
players of the TOR pathway (L, TSC1, TSC2, TOR-C2 and
TOR-C1).
Overall, these effects show a strong negative feedback that is
consistent amongst long-lived mutants and opposite between
short- and long-lived mutants. This type of negative feedback leads
to homeostasis, in an attempt to reverse the effects of the primary
mutations.
An S6K-CHICO mediated feedback is identified in the
long-lived fly mutants in vivo
Looking at the shortest paths derived from the Lnk mutant, we
identified a novel hypothesis that involves a possible feedback
(secondary effect) route from the up-regulation of Atg1 to lifespan
reduction via S6K inactivation and CHICO activation, uncover-
ing a possible cross-talk between IIS and TOR signalling (Table 1).
Although none of the genes whose proteins take part in this signal
are differentially expressed in the InR mutant, we observed sub-
paths containing the S6K signal (Figure 5), suggesting that it could
play a role in this mutant too. This signal was absent from our
third long-lived mutant, chico, since it requires that chico is
activated, impossible in the chico knock out.
Table 1. Shortest paths of potentially active primary and secondary effects inferred per experiment.
chico Primary Effects chico; Pi3K; Akt1; foxo: longevity:
Negative Feedback Ilp2: InR: Lnk: Pi3K: Akt1: foxo; longevity;
Ilp3: InR: Lnk: Pi3K: Akt1: foxo; longevity;
Ilp5: InR: Lnk: Pi3K: Akt1: foxo; longevity;
Lnk Primary Effects Lnk; Pi3K; Akt1; foxo: longevity:
Negative Feedback Ilp2: InR: chico: Pi3K: Akt1: foxo; longevity;
Ilp3: InR: chico: Pi3K: Akt1: foxo; longevity;
Ilp5: InR: chico: Pi3K: Akt1: foxo; longevity;
Ilp6: InR: chico: Pi3K: Akt1: foxo; longevity;
ImpL2: Ilp2: InR: chico: Pi3K: Akt1: foxo; longevity;
ImpL2: Ilp5: InR: chico: Pi3K: Akt1: foxo; longevity;
wdb; Akt1: foxo; longevity;
chico: Pi3K: Akt1: foxo; longevity;
Atg1: S6k; chico: Pi3K: Akt1: foxo; longevity;
InR Primary Effects InR; chico; Pi3K; Akt1; foxo: longevity:
InR; Lnk; Pi3K; Akt1; foxo: longevity:
Positive Feedback Tak1: hep: bsk: foxo: longevity:
Negative Feedback L: TOR-C1; TOR-C2: Akt1: foxo; longevity;
foxo Primary Effects foxo; longevity;
Positive Feedback Pk61C: Akt1: foxo ; longevity;
hpo; foxo; longevity;
Pten; Akt1: foxo; longevity;
doi:10.1371/journal.pone.0050881.t001
Table 2. Signalling sub-path example.
Ilp2: InR: Lnk: Pi3K: Akt1: foxo; longevity;
Ilp3: InR: Lnk: Pi3K: Akt1: foxo; longevity;
Ilp5: InR: Lnk: Pi3K: Akt1: foxo; longevity;
In this example there are three different signals that only differ by the type of
ILPs that trigger INR and the rest of the IIS pathway via LNK. When comparing
these, it is often useful to ignore the ILPs and use for our analyses the longest
common string, which in this case is the signalling cascade downstream of each
ILP.
doi:10.1371/journal.pone.0050881.t002
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Partial support for this hypothesis comes from a study in [48],
who demonstrated that when Tsc1 and Tsc2 are knocked out, there
is a negative feedback to CHICO and ultimately AKT1 via S6K.
In the case of the Lnk mutant we do not observe a down-regulation
of Tsc1 or Tsc2, but we observe an up-regulation of Atg1, which
acts downstream of TSC1/TSC2. It would be interesting to
investigate whether this negative feedback via S6K is indeed active
in the Lnk mutant. Finally, it has been shown that the ribosomal S6
kinase 1 deletion causes lifespan extension in mice [8]. Although
S6K1 inhibits the insulin pathway in mice [49], lifespan-extension
most likely occurs by a different route rather than by interference
with the insulin pathway and FOXO given that there are no
known outgoing connections from the S6K or any downstream
connections towards the IIS, except for the inhibition of CHICO
by S6K. It would be interesting to compare the IIS and TOR
pathways and equivalent experiments between the two species, in
order to understand in depth the mechanisms under which S6K
contributes to lifespan and where these intersect across species.
Identifying contradictions and targets for further work
We observed that Thor and myc, both targets of the TOR
pathway, but also targets of other pathways, appear to be up-
regulated both in the short-lived foxo flies, as well as in one of the
long-lived mutants (InR). A possible hypothesis is that they do not
Figure 5. Links derived by sub-path comparisons and their suggested impact on longevity. (A) The link between the inactivated S6K and
activated CHICO is found in several sub-paths in the lnK and the InR mutant and is suggested to act as a secondary effect, reducing lifespan by FOXO
inhibition. (B) Another commonly found link in several sub-paths of Lnk and InR and some paths of chico is the activation of AKT1 by TOR-C2,
suggesting a secondary effect and a crosstalk between TOR and IIS pathways. (C) The link of L inactivating TOR-C1 by inhibition is found in both Lnk
and InR, as well some paths of chico. In the InR experiment L appears to be up-regulated, further supporting a possible secondary effect on longevity
through TOR-C2 and AKT1. (D) Another route to AKT1 activation by TOR-C2 activation, also found in both InR and Lnk sub-paths, as well as some
paths of chico, involved the inactivation of RHEB by the TSC1 and TSC2 complex.
doi:10.1371/journal.pone.0050881.g005
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play a primary role in lifespan and there is another process
regulating them that is currently not included in our pathway
model. Another example of missing information is gene L, also
known as lobe, which is involved in a cross-talk between AKT1 in
the IIS pathway and the TOR pathway, TOR-C1 complex. In our
examples, we observed L to be up-regulated in the InR mutant,
where it is suggested to be involved in a secondary effect by
providing feedback to AKT1 through the TOR complex.
According to its functional description in Flybase (ID:
FBgn0001332), it also appears to be implicated in the regulation
of the Wnt signalling and of the JNK cascade, although there is no
evidence of the underlying mechanism.
In the InR experiment we also observed up-regulation of Tak1, a
component of the JNK pathway. This pathway is ubiquitous, in
being involved in many different biological processes. It has been
implicated in lifespan through FOXO activation [50]. The
mechanism under which the JNK signals integrate with the IIS
signals is unclear, but the JNK pathway is known to antagonise the
IIS. In our example, TAK1 leads to a positive feedback effect by
activating FOXO. Other examples of such positive feedback
effects are Pk61C up-regulation and the hpo and Pten down-
regulations in the foxo knock-out experiment. All three of them
lead to an inactivation of FOXO according to our current
pathway knowledge, indicating possible points for further research.
We could not identify any direct paths to FOXO and longevity
from p110, the kinase subunit of the PI3K complex, but we noticed
that it is over-expressed in two different lifespan-extending
experiments. We believe that this highlights the need for further
investigations on this kinase and its role in ageing via insulin
pathway perturbations.
Discussion
Our method successfully combines knowledge of the IIS and
TOR pathways with gene expression data sets and longevity
assays, to make inferences about the modulation of the signals in
different mutants of the IIS pathway and explain the observed
phenotypes. Such insight in the modulation of signal transduction
cannot routinely be gained experimentally from such in vivo
experiments, although it is important in order to be able to
uncover the complexities of ageing. A strength of our approach is
that it enables us to investigate data sets from many experiments in
a fast, simple and rigorous way, uncover detailed paths per
experiment, as well as consistent biological trends across exper-
iments, such as the homeostatic behaviour observed across the
different mutants. Such insights cannot be produced by standard
functional analysis methods for gene expression data sets.
Moreover, the application of a computationally efficient and
scalable method such as ASP enables the development of web-
services, making such complex analyses easier to perform and
accessible to experimental scientists.
An assumption that our pathway model makes is that longevity
is solely a result of FOXO activation via the insulin pathway,
which is primarily a nutrient sensing pathway coordinating
appropriate responses to nutrient availability. Although extensive,
our pathway model ignores further complexities of the interactions
with other pathways or other determinants of lifespan. By
including components of the TOR pathway in our model,
especially where this cross-talks with the IIS pathway, we were
able to identify how TOR could provide feedback into the IIS
pathway under the conditions of certain IIS perturbations.
However, the TOR pathway has also been implicated in lifespan
possibly through different routes, as demonstrated in other
organisms [8]. Moreover, it is unknown how the gene targets of
FOXO affect lifespan in the fly. Such information would enable a
more complete analysis and a better interpretation of the results on
the foxo mutant. Although the majority of our results are consistent
with previous knowledge and we are still able to generate
interesting hypotheses for further investigations, we can not assign
roles or causes for the differential expression of genes that trigger
positive feedback with respect to FOXO-mediated longevity.
By formulating our problem as a logic-based theory, we are able
to use the efficient search facilities of Answer Set Programming
and can therefore explore larger pathways. Secondly, we take
advantage of the rich and expressive language of formal logic to
combine different types of data sets and reason about them in a
biologically meaningful way, by formalising in a rule-based
representation the implicit reasoning of biologists, when consid-
ering such data sets. This largely qualitative method is very useful
for combining different, large data sets, testing their consistency
with known phenotypes, predicting phenotypes according to the
pathway model and generating hypotheses that could be
investigated further by more detailed experimental and quantita-
tive computational approaches. Moreover, the ASP framework
and the available solvers generate all possible solutions (answer
sets) to a problem, given the input data at hand. Specific signals
involving smaller segments of the pathway, such as the feedback
mediated by ATG1, S6K and CHICO in the Lnk mutant, can be
investigated by further experiments. For example, western-blot
analysis can be performed in time-series experiments after
pathway induction by ligand stimulation and their impact on
longevity can then be studied by dynamic simulations. However,
such experiments, validating our hypotheses, would benefit from
the use of different biological systems, such as cell line models,
instead of in vivo whole-organism models that have been used for
the gene expression and lifespan assays.
In the majority of cases, primary effects reflect the impact of the
perturbation on lifespan, whereas secondary effects seem to be
parts of feedback mechanisms that lead to homeostasis, attempting
to ‘‘correct’’ the effect of the experimental perturbation. When
comparing the long-lived mutants against the foxo knock out, the
only short-lived mutant, we generally observe opposite effects on
differential expression of the insulin pathway components. For
example, in all long-lived mutants we observe at least one Ilp per
experiment being up-regulated, in order to stimulate the pathway
and lead to FOXO inactivation by facilitating its retention in the
nucleus. Conversely, in the short-lived experiment we observe
down-regulation of Ilps. Similarly, the inhibitor of ILP2 and ILP5,
IMPL2, is down-regulated in the Lnk mutant and up-regulated in
the foxo mutant.
Moreover, studying the predicted signals in the different
mutants associated with differences in longevity, we are able to
generate hypotheses on how lifespan could be modulated within
the pathway framework, not only per mutant, but also across
mutants. Interesting questions for further investigations are (1)
whether the primary and secondary effects, as presented here,
represent opposing contributions to the overall longevity pheno-
type we observe in the survival studies and (2) whether it would be
possible to quantify these effects and identify a relationship
between each signal and difference in lifespan. Moreover, our
current pathway model ignores the contribution of other pathways
and processes, e.g. growth/autophagy, to lifespan by solely
examining lifespan as a result of FOXO activation. It could be
possible, in the future, to integrate methods that employ dynamic
simulations, such as the one used by Dalle Pezze et al [51], in order
to delineate the complex effects of the different signals on FOXO
for each mutant.
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Our application is limited by the lack of kinetic information on
the pathways and also by the experimental data sets, which
contain mRNA levels, making the quantitative analyses of
signalling pathways impossible. Moreover, we integrate pathway
connections derived by different experimental methodologies,
while the accuracies of these connections are ignored by the
analyses, because they are sometimes unavailable or unsuitable for
simulations. However, since we have been strict in only selecting
connections that have been experimentally verified, our method
gains in strength by the use of larger but qualitative pathway
diagrams thus making their analysis possible in a qualitative
fashion, as opposed to the computational difficulties faced by
quantitative methods and discrete logic-based methods, to
simulate larger pathways.
It would be an interesting exercise to test on a smaller example
the performance of tools implementing Markov Logic Networks,
e.g. Alchemy by Domingos et al [52], which combine statistical
relational learning with knowledge-based model construction. We
believe that the improvement of the formal logic-based reasoning
methods and their integration with statistical methods will lead to
the development of hybrid approaches that can leverage
quantitative information where available, but also take advantage
of the rich representational language to combine disparate and
qualitative data sets in order to generate more accurate and
meaningful biological hypotheses.
The rule-based model itself is general and can be used to reason
about different types of pathways, other than the IIS and TOR
pathway and relate these to phenotypes other than longevity. In
the future, we will enable the import of user-defined pathways to
the web-service, so that users could relate their molecular data sets
to their pathways of interest. It is important that for the inclusion
of different types of pathway models we develop further the web-
service, so that it is compatible with standard pathway formats,
such as BioPAX and SBML.
Our current pathway model aims to represent the topology of
the interactions without including constraints on the conditions or
tissues, where these interactions take place. Such information,
once available in sufficient detail to have an impact on the
analyses, could potentially be collected and included in the rule-
based logic program. We anticipate that the modular nature of our
model will enable it to expand and combine pathway processes at
different levels of detail (e.g. undirected Protein-Protein Interac-
tion Networks), as new information on tissues, granularity of
pathway interactions becomes available. Currently, the longevity
phenotype is considered in a discrete fashion as ‘‘long-lived’’,
‘‘unchanged’’, or ‘‘short-lived’’. In the future, we aim to integrate
the methods implemented in the web-service SurvCurv (manu-
script in preparation) with the methods in NetEffects in order to
achieve a more quantitative and full representation of longevity
phenotypes.
As it stands, the pathway model and the ASP methods can be
used to investigate the signalling effects on the IIS pathway by
longevity experiments that involve exposure to environmental
stress conditions or perturbations of other genes, not included in
the IIS pathway. A requirement is that some of the components in
the pathway model must be differentially expressed in these
experiments, therefore implicating the IIS pathway in the response
to the experimental condition. For example, these could include
dietary restriction experiments or perturbation of other transcrip-
tion factors that have also been shown to alter ageing. In the future
we also aim to generalise the web-service to include the longevity-
related pathways of other model organisms used in ageing
research, such as C.elegans and M.musculus, with the aim of
performing cross-species data analyses to investigate how the
predicted signals in equivalent mutants differ across species.
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